Advanced Practice Midwife in Hanover, MD Accepting Medicare

2 Advanced Practice Midwife nurses found. Showing 1 - 2

Kendall Parsons, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 7556 Teague Rd Ste 430, Hanover, MD 21076 Phone: 410-553-8260

Marissa Lindsay Stear, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7556 Teague Rd Ste 430, Hanover, MD 21076 Phone: 410-553-8260

News Archive

Researchers identify age-dependent beta cell proliferation pathway

As a person ages, the ability of their beta cells to divide and make new beta cells declines. By the time children reach the age of 10 to 12 years, the ability of their insulin-producing cells to replicate greatly diminishes. If these cells, called beta cells, are destroyed-as they are in type 1 diabetes-treatment with the hormone insulin becomes essential to regulate blood glucose levels and get energy from food.

New brain mapping model could improve success rate of transcranial magnetic stimulation

Brain researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a new brain mapping model which could improve the success rate of transcranial magnetic stimulation (TMS) in treating conditions including depression, neuropathic pain, and stroke.

‘Grade A' all-American pot: The next big export?

In a large warehouse, LivWell Enlightened Health feeds its cloned cannabis plants a custom blend of nutrients, sprays them with filtered water and pumps extra carbon dioxide into the air.

Researchers visually capture 'shapeshifter' that regulates blood clotting

We are normally born with a highly sophisticated array of molecules that act as "sentries," constantly scanning our bodies for injuries such as cuts and bruises.

Senomyx prices common stock offering at $2.80 per share

Senomyx, Inc. announced today the pricing of an underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $2.80 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $20.0 million. The offering is expected to close on or about February 18, 2010, subject to customary closing conditions. Senomyx has also granted the underwriters a 30-day option to purchase up to an aggregate of 1,071,428 additional shares of common stock to cover over-allotments, if any.

Read more Medical News

› Verified 3 days ago